Ion Beam Applications SA (LON:0GZK)

Market Cap	384.10M +28.1%
Revenue (ttm)	550.23M +7.1%
Net Income	21.19M +44.7%
EPS	0.69 +38.9%
Shares Out	n/a
PE Ratio	18.12
Forward PE	18.93
Dividend	0.15 (1.10%)
Ex-Dividend Date	Jun 15, 2026

Volume	163
Open	15.58
Previous Close	15.50
Day's Range	15.30 - 15.60
52-Week Range	9.91 - 17.72
Beta	1.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Ion Beam Applications

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak; DynamicARC, a technique that allows dynamic spot scanning irradiation and energy switching while the gantry is rotating; Proteus ONE, a compa...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1986
• Employees: 2,264
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GZK

Financial Performance

In 2025, Ion Beam Applications's revenue was 620.18 million, an increase of 24.49% compared to the previous year's 498.16 million. Earnings were 12.73 million, an increase of 37.59%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 8, 2026

Data Sources Report a data error